R. Rółkowski

The involvement of AT2-receptor in the antithrombotic effect of losartan in renal hypertensive rats

D. Pawlak, W. Buczko, T. Matys, 2000 .

The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats.

D. Pawlak, W. Buczko, T. Matys, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats.

D. Pawlak, W. Buczko, R. Pawlak, 1998, Thrombosis research.

The antithrombotic effect of angiotensin-(1—7) closely resembles that of losartan

D. Pawlak, W. Buczko, T. Matys, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Antithrombotic activity of losartan in two kidney, one clip hypertensive rats. A study on the mechanism of action.

W. Buczko, R. Pawlak, E. Chabielska, 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.

W. Buczko, T. Matys, R. Pawlak, 2000, Journal of cardiovascular pharmacology.

Cyclophosphamide in diffuse lung damage.

E. Jabłońska, B. Musiatowicz, M. Sułkowska, 1997, Roczniki Akademii Medycznej w Bialymstoku.

Propranolol prevents the development of venous thrombosis in rats by a platelet-dependent mechanism.

W. Buczko, R. Pawlak, M. Gruszecki, 2001, Polish journal of pharmacology.